SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWatkin Jones Regulatory News (WJG)

Share Price Information for Watkin Jones (WJG)

Share Price is delayed by 15 minutes
Get Live Data
19.50    0.00 (0.00%)
Bid:
19.70
Ask:
19.88
Spread: 0.18 (0.914%)
Market Cap: £50.09m
WJG Live PriceLast checked at - London Stock Exchange

Intraday Watkin Jones Share Chart

Forward sale & development agreement

30 Aug 2017 07:00

RNS Number : 2295P
Watkin Jones plc
30 August 2017
 

For immediate release

30 August 2017

 

 

Watkin Jones plc

('Watkin Jones' or the 'Group')

 

Completion of a forward sale and a development agreement for two developments

 

Watkin Jones plc (AIM:WJG), a leading UK developer and constructor of multi occupancy property assets, with a focus on the student accommodation sector, is pleased to announce that the Group has forward sold a development of 354 beds on Little Patrick Street in Belfast and completed a development agreement to deliver 972 beds on the Hollis Croft scheme in Sheffield to the same institutional investor. The consideration payable to Watkin Jones plc over the course of the developments is circa £90 million, net of client funding costs.

 

Both developments are due for completion for the summer of 2019 and, following these agreements, Watkin Jones have now forward sold 1,981 of the 3,545 beds planned to be delivered ahead of the 2019/2020 academic year. All schemes to be delivered during FY17 and FY18 and ahead of the 2017/2018 and 2018/2019 academic years have been forward sold.

 

Mark Watkin Jones, Chief Executive Officer of Watkin Jones plc, said: "We are delighted to announce that we have successfully completed the forward sale of a development for 354 beds in Belfast and entered into a development agreement to deliver 972 beds in Sheffield for the same institutional investor. Combined the developments are worth circa £90 million to the Group and both developments are to be completed ahead of the 2019/2020 academic year. We now have revenue and earnings visibility on 1,981 of the 3,545 beds we plan to deliver in FY19, with the remaining beds having been secured and working through the early stages of our business model.

 

"These agreements further demonstrate the Group's strong and growing relationships with institutional investors, as well as the continuing demand for high quality purpose built student accommodation. Our ability to secure, fund and develop a pipeline of attractive sites provides excellent earnings visibility for our shareholders."

 

- Ends -

 

 

For further information:

Watkin Jones plc

 

Mark Watkin Jones, Chief Executive Officer

Tel: +44 (0) 1248 362 516

Phil Byrom, Chief Financial Officer

www.watkinjonesplc.com

 

 

Peel Hunt LLP (Nominated Adviser & Joint Corporate Broker)

Tel: +44 (0) 20 7418 8900

Mike Bell / Justin Jones / Matthew Brooke-Hitching

www.peelhunt.com

 

 

Jefferies Hoare Govett (Joint Corporate Broker)

Tel: +44 (0) 20 7029 8000

Max Jones / Will Souter

www.jefferies.com

 

Media enquiries:

Buchanan

 

Henry Harrison-Topham / Richard Oldworth

Jamie Hooper / Steph Watson

 

Tel: +44 (0) 20 7466 5000

watkinjones@buchanan.uk.com

www.buchanan.uk.com

 

 

Notes to Editors

 

Watkin Jones is a leading UK developer and constructor of multi occupancy property assets, with a focus on the student accommodation sector. The Group has strong relationships with institutional investors, and a good reputation for successful, on-time-delivery of high quality developments. Since 1999, Watkin Jones has delivered over 31,800 student beds across 98 sites, making it a key player and leader in the UK purpose built student accommodation market. In addition, Watkin Jones has been responsible for over 50 residential developments, ranging from starter homes to executive housing and apartments.

 

The Group's competitive advantage lies in its experienced management team and business model, which enables it to offer an end-to-end solution for investors, delivered entirely in-house with minimal reliance on third parties, across the entire life cycle of an asset. 

 

Watkin Jones was admitted to trading on AIM in March 2016 with the ticker WJG.L. For additional information please visit: www.watkinjonesplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGROKCDPABKDCFB
Date   Source Headline
1st Jun 20267:00 amRNSChange of Registered Office
28th May 20263:00 pmRNSInvestor Presentation via Investor Meet Company
27th May 20267:00 amRNSHalf Year Results
19th May 20267:00 amRNSNotice of H1-2026 Results
1st May 20267:00 amRNSTotal Voting Rights
29th Apr 20267:00 amRNSHY 2026 Trading Update
13th Apr 20261:50 pmRNSHolding(s) in Company
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20264:20 pmRNSHolding(s) in Company
25th Mar 20264:14 pmRNSHolding(s) in Company
11th Mar 20262:39 pmRNSHolding(s) in Company
27th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20262:00 pmRNSResult of AGM
3rd Feb 202611:46 amRNSBlocklisting Application
28th Jan 20261:26 pmRNSHolding(s) in Company
20th Jan 20267:00 amRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSAnnual Report and Notice of AGM
22nd Dec 20257:00 amRNSDevelopment Partnership for 294-unit hotel
22nd Dec 20257:00 amRNSDevelopment Partnership for 294-unit hotel
19th Dec 202512:02 pmRNS-RProgressive publishes new research
19th Dec 202512:02 pmRNS-RProgressive publishes new research
17th Dec 20258:17 amRNSPresentation via Investor Meet Company
16th Dec 20257:00 amRNSFull Year Results
15th Dec 20251:10 pmRNSWJ & Maslow Capital announce £102m PBSA scheme
21st Oct 20257:00 amRNSFY25 Trading Update
1st Oct 202510:44 amRNSHolding(s) in Company
30th Sep 20257:00 amRNSWatkin Jones announces £182m PBSA Joint Venture
10th Sep 20257:00 amRNSHolding(s) in Company
5th Sep 20257:00 amRNSAppointment of Joint Corporate Broker
4th Sep 202512:54 pmRNSHolding(s) in Company
12th Aug 20257:00 amRNSDevelopment Partnership for 200-unit PBSA scheme
1st Jul 20257:00 amRNSIssue of Sharesave options and PDMR shareholdings
29th May 20253:36 pmRNSPresentation via Investor Meet Company
29th May 20257:00 amRNSHalf Year Results
28th May 202511:56 amRNSHolding(s) in Company
22nd May 20257:00 amRNSNotice of H1-2025 Results
29th Apr 20257:00 amRNSHY25 Trading Update
4th Apr 20257:00 amRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSHolding(s) in Company
4th Mar 20254:12 pmRNSNotification of Major Holdings
4th Mar 20252:26 pmRNSResult of AGM
12th Feb 20252:11 pmRNSNotification of Major Holdings
7th Feb 20257:50 amRNSAnnual Report and Notice of AGM
5th Feb 20257:00 amRNSDirector/PDMR Shareholding
31st Jan 20259:53 amRNSDevelopment Partnership for 260-unit Aparthotel
27th Jan 20254:59 pmRNS-RPresentation via Investor Meet Company
27th Jan 20254:55 pmRNSPresentation via Investor Meet Company
27th Jan 20251:23 pmRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSFull Year Results 2024
17th Jan 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.